Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

DEKON AGR (02419) spent 417,000 Hong Kong dollars to repurchase 5800 shares on February 16th.
.png)
MNSO (09896) spent 30,300 Hong Kong dollars to repurchase 800 shares on February 16th.

CHU KONG SHIP (00560) issues profit warning, expecting annual attributable net comprehensive profit of approximately HK$41 million to HK$55 million, a decrease of approximately 53%-65% year-on-year.
DEKON AGR (02419) spent 417,000 Hong Kong dollars to repurchase 5800 shares on February 16th.

MNSO (09896) spent 30,300 Hong Kong dollars to repurchase 800 shares on February 16th.
.png)
CHU KONG SHIP (00560) issues profit warning, expecting annual attributable net comprehensive profit of approximately HK$41 million to HK$55 million, a decrease of approximately 53%-65% year-on-year.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


